Simvastatin Efficiently Reduces Levels of Alzheimer’s Amyloid Beta in Yeast
A large-scale epidemiology study on statins previously showed that simvastatin was unique among statins in reducing the incidence of dementia. Since amyloid beta (Aβ42) is the protein that is most associated with Alzheimer’s disease, this study has focused on how simvastatin influ...
Main Authors: | Sudip Dhakal, Mishal Subhan, Joshua M. Fraser, Kenneth Gardiner, Ian Macreadie |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/20/14/3531 |
Similar Items
-
Protein Homeostasis Networks and the Use of Yeast to Guide Interventions in Alzheimer’s Disease
by: Sudip Dhakal, et al.
Published: (2020-10-01) -
Tyramine and Amyloid Beta 42: A Toxic Synergy
by: Sudip Dhakal, et al.
Published: (2020-05-01) -
A Toxic Synergy between Aluminium and Amyloid Beta in Yeast
by: Jamieson B. Mcdonald, et al.
Published: (2021-02-01) -
<i>Trans</i>-Chalcone Plus Baicalein Synergistically Reduce Intracellular Amyloid Beta (Aβ<sub>42</sub>) and Protect from Aβ<sub>42</sub> Induced Oxidative Damage in Yeast Models of Alzheimer’s Disease
by: Sudip Dhakal, et al.
Published: (2021-08-01) -
Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice
by: Xin-Kang Tong, et al.
Published: (2009-09-01)